The Fertility Services Market Report is Segmented by Procedures (In-Vitro Fertilization (IVF), Artificial Insemination, Surrogacy, and Others), Services (Donor Services and Non-Donor Services), Service Provider (Fertility Clinics, Hospitals, and Others), Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD) for the Above-Mentioned Segments.

Snapshot img

Fertility Services Market Size 2025-2029

The fertility services market size is forecast to increase by USD 9.53 billion, at a CAGR of 7.8% between 2024 and 2029.

The market is a continually evolving landscape, driven by various factors that shape its dynamics. One significant trend is the increasing demand for fertility treatments due to the rising prevalence of late parenthood. According to recent studies, the number of women giving birth over the age of 35 has increased by 23.3% in the last decade. This demographic shift has led to a surge in demand for assisted reproductive technologies, including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Moreover, the market is also influenced by the growing incidence of prostate cancer, which can impact male fertility. According to the American Cancer Society, there will be approximately 193,000 new cases of prostate cancer diagnosed in the US in 2022.
This statistic underscores the importance of fertility services in addressing the reproductive health needs of cancer survivors. Despite these growth opportunities, the market faces challenges, including high complication rates associated with fertility treatments. For instance, the risk of multiple pregnancies and ovarian hyperstimulation syndrome (OHSS) are significant concerns. These complications can lead to increased healthcare costs and potential long-term health risks for patients. The market is a complex and dynamic industry, shaped by demographic trends, health concerns, and technological advancements. As the demand for fertility treatments continues to rise, stakeholders must navigate the challenges and opportunities that come with this evolving landscape.

Major Market Trends & Insights

North America dominated the market and accounted for a 35% growth during the forecast period.
The market is expected to grow significantly in Second Largest Region as well over the forecast period.
By the Service, the Treatment services sub-segment was valued at USD 6.65 billion in 2023
By the End-user, the Fertility clinics sub-segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 89.23 billion
Future Opportunities: USD USD 9.53 billion 
CAGR : 7.8%
North America: Largest market in 2023

What will be the Size of the Fertility Services Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

Fertility services encompass a range of medical interventions and technologies designed to help individuals and couples achieve pregnancy. One significant area within this market is the use of fertility medications, which play a crucial role in assisted reproductive technology (ART). According to recent reports, approximately 12% of women in the United States have used some form of fertility medication. ART involves various techniques, including artificial insemination, ovulation predictor kits, and ovarian stimulation protocols, among others. Cervical mucus plays a vital role in the natural process of conception, but ART may bypass this step through the use of intrauterine insemination (IUI) or in vitro fertilization (IVF).
In IUI, semen cryopreservation is essential for the success of the procedure. Ovarian stimulation protocols, such as ovulation induction, are commonly used in ART to increase the number of mature follicles and improve the chances of successful pregnancy. Ovulation predictor kits help individuals monitor their menstrual cycle and identify the most fertile days for conception. Despite the advancements in fertility services, challenges persist. Miscarriage rates remain a concern, with approximately 10-20% of known pregnancies ending in miscarriage. Blastocyst development is a critical factor in the success of ART, with implantation rate and pregnancy rate being essential indicators of treatment efficacy.
Reproductive endocrinology, a subspecialty of obstetrics and gynecology, focuses on the diagnosis and treatment of infertility. Donor insemination and ectopic pregnancy are other areas of fertility services that have gained increasing attention. Embryo culture media and ultrasound imaging are essential tools used in the field to monitor the development of embryos and assess the progress of pregnancies. Looking ahead, the market is expected to grow substantially. According to market reports, the global ART market is projected to expand at a significant rate, with an increase of around 15% in the number of ART cycles performed annually.
This growth is driven by factors such as rising infertility rates, increasing awareness, and advancements in technology. Comparing the growth rates of different regions, Asia Pacific is expected to witness the fastest growth in the ART market due to factors such as increasing disposable income, changing social norms, and government initiatives to promote fertility treatments

The global fertility services market was valued at ** billion U.S. dollars in 2018, this value was forecast to more than double by 2026, reaching ** billion U.S. dollars. Women choosing to have children at a later age is said to be a large factor behind the growth of this market as more people will require fertility services.

The global fertility services market, valued at $19.72 billion in 2025, is projected to experience robust growth, driven by rising infertility rates worldwide, advancements in assisted reproductive technologies (ART), and increased awareness about fertility treatments. The market's Compound Annual Growth Rate (CAGR) of 7.18% from 2025 to 2033 signifies a substantial expansion, indicating significant potential for investment and market entry. Key growth drivers include the increasing prevalence of lifestyle factors contributing to infertility (such as delayed childbearing and increased stress), growing disposable incomes in developing economies leading to greater access to fertility services, and continuous technological advancements in ART, such as intracytoplasmic sperm injection (ICSI) and preimplantation genetic testing (PGT). The market is segmented by service type (treatment services, testing and storage services, others) and end-user (fertility clinics, hospitals, surgical centers, clinical research institutes). Treatment services represent the largest segment, reflecting the significant demand for procedures like in-vitro fertilization (IVF). North America and Europe currently dominate the market due to higher adoption rates of ART and advanced healthcare infrastructure; however, the Asia-Pacific region is poised for substantial growth, fueled by increasing awareness and rising disposable incomes. Competitive dynamics are shaped by both large multinational corporations and specialized fertility clinics, highlighting a mixed landscape of established players and emerging innovators. The market faces certain restraints, including high treatment costs and associated financial burdens for patients, stringent regulatory frameworks governing ART procedures varying across geographies, ethical considerations surrounding assisted reproduction, and varying levels of insurance coverage for infertility treatments. Despite these challenges, the overall market outlook remains positive, largely due to the increasing demand for fertility services, particularly among older women seeking parenthood and couples struggling with infertility. The ongoing research and development in ART promises to further expand market opportunities in the coming years. The leading companies are strategically focusing on geographical expansion, technological innovation, and strategic partnerships to enhance their market position and capture a larger share of this expanding market.

As per Cognitive Market Research's latest published report, the Global Fertility Services market size was $22.13 Billion in 2022 and it is forecasted to reach $ 89.79 Billion by 2030. Fertility Services Industry's Compound Annual Growth Rate will be 15.11% from 2023 to 2030. Factors Affecting Fertility Services Market Growth

Increasing unhealthy lifestyles in male and female populations like consumption of alcohol, smoking, and lack of physical activity is the key factor expected to drive the growth of the fertility services market. In addition, increasing in vitro fertilization with intracytoplasmic sperm injection technology owing to the high success rate in treating infertility is expected to drive the growth of the target market. Furthermore, an increasing number of product launches and approvals for fertility services products creates growth opportunities for the global fertility services market. However, increasing the cost of the IVF procedure and lack of awareness among the population may hamper the growth of the fertility services market. What are Fertility Services?

Fertility service is a procedure that provides treatment for infertility. Fertility problems with semen ejection, a lack of sperm, low sperm counts, unusual sperm shape, and motility are the causes of infertility in men. Numerous illnesses affect the ovaries, uterus, fallopian tubes, and endocrine system, among other organs, which cause infertility in women. The three main types of treatments for infertility include prescription drugs, surgeries, and services for assisted conception.

Fertility Services Market Outlook

As per our latest research, the global fertility services market size reached USD 25.6 billion in 2024, reflecting a robust expansion driven by rising infertility rates, technological advancements, and increasing awareness regarding fertility solutions. The market is projected to grow at a CAGR of 8.2% from 2025 to 2033, leading to a forecasted value of USD 50.1 billion by 2033. This strong growth trajectory is primarily attributed to the growing prevalence of infertility, delayed parenthood, and a surge in demand for assisted reproductive technologies (ARTs) worldwide.

One of the most significant growth factors for the fertility services market is the increasing incidence of infertility among both men and women globally. Factors such as changing lifestyles, rising stress levels, late marriages, and higher maternal ages have contributed to the rise in infertility rates. According to the World Health Organization, infertility affects about 15% of reproductive-aged couples worldwide, fueling the need for effective fertility treatments. The social acceptance of fertility treatments has also improved, with more couples seeking medical assistance, further driving the market's expansion.

Technological advancements in assisted reproductive technologies, including in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and other innovative procedures, have significantly improved success rates and patient outcomes. The integration of artificial intelligence, genetic testing, and cryopreservation techniques has enhanced the efficacy and accessibility of fertility services. These innovations have reduced procedural risks, increased the chances of successful pregnancies, and broadened the scope of fertility treatments to address complex infertility issues, thereby strengthening the overall growth of the fertility services market.

Government initiatives and favorable reimbursement policies in several countries have also played a crucial role in market expansion. Many governments are recognizing infertility as a public health issue and are implementing supportive regulations and funding for fertility treatments. Additionally, the proliferation of fertility clinics, especially in emerging economies, has improved access to advanced reproductive healthcare. The rise in medical tourism, particularly in countries offering cost-effective fertility treatments, has further contributed to the global growth of this market.

In recent years, the role of IVF Clinic Insurance has become increasingly significant in the fertility services market. As the costs associated with advanced reproductive technologies like IVF continue to rise, insurance coverage can provide much-needed financial relief for individuals and couples seeking fertility treatments. Many insurance providers are recognizing the importance of supporting reproductive health and are expanding their coverage options to include various fertility services. This shift not only alleviates the financial burden on patients but also encourages more people to pursue fertility treatments, thereby contributing to the growth of the market. The availability and extent of IVF Clinic Insurance can vary widely by region, with some countries offering comprehensive coverage while others have more limited options. As awareness and demand for fertility services increase, the expansion of insurance coverage is expected to play a crucial role in making these treatments more accessible and affordable.

Regionally, North America and Europe have traditionally dominated the fertility services market due to advanced healthcare infrastructure, higher awareness, and supportive regulatory frameworks. However, the Asia Pacific region is emerging as a significant growth hub, driven by a large patient pool, increasing disposable incomes, and rapidly evolving healthcare systems. The Middle East & Africa and Latin America are also witnessing steady growth, supported by rising awareness and gradual improvements in healthcare services. This dynamic regional landscape is expected to shape the competitive and strategic direction of the fertility services market over the forecast period.

Recent developments include: In June 2023, Quantum Health partnered with Progyny, Inc. to introduce Quantum Health’s Comprehensive Care Solutions platform for family building and fertility solutions , In April 2023, Cryoport, Inc. signed 3 years supply chain agreement with the Boston IVF to support the reproductive material shipment across the U.S. .

The global fertility services market was worth around $26,362 million in 2021 and is predicted to grow to around $36,256 million by 2028 at a CAGR rate of 7% over the forecast

Global Fertility Services Market is segmented by Application (Reproductive Health_ Infertility Treatment_ Healthcare), Type (In Vitro Fertilization (IVF)_ Intrauterine Insemination (IUI)_ Egg Freezing_ Sperm Freezing), and Geography (North America_ LATAM_ West Europe_Central & Eastern Europe_ Northern Europe_ Southern Europe_ East Asia_ Southeast Asia_ South Asia_ Central Asia_ Oceania_ MEA)

The Fertility Treatment Market Report is Segmented by Gender (Female Infertility and Male Infertility), Treatment Type (In-Vitro Fertilization (IVF), and More), Procedure/Cycle Type (Fresh Non-Donor, and More), Service Provider (Fertility Clinics & ART Centres, and More), Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).

The Fertility Services report provides a detailed analysis of emerging investment pockets, highlighting current and future market trends. It offers strategic insights into capital flows and market shifts, guiding investors toward growth opportunities in key industry segments and regions.

Fertility Services Market is projected to reach USD 80.1 billion by 2033, growing at a CAGR of 9.4% from 2025-2033.

The size of the India Fertility Services Market was valued at USD 1.98 Billion in 2023 and is projected to reach USD 6.12 Billion by 2032, with an expected CAGR of 17.50% during the forecast period. Recent developments include: October 2020: Nova IVF Fertility, India's major IVF chain, has introduced a new state-of-the-art IVF center in Patna. With an inheritance spanning 10 yrs in the field of helped reproductive therapy & over 35000 IVF pregnancies, Nova IVF brings in the most cutting-edge fertility treatment to Eastern India.. Notable trends are: Increased awareness of infertility treatments is driving market growth..

US Fertility Services Market growth is driven by rising infertility rates, increasing acceptance of assisted reproductive technologies, and advancements in treatment methods.

The Global Fertility Services market will exceed USD 60.29 Billion by 2030 at 9.02 percent CAGR, driven by demand for IVF and ART solutions.

North America Fertility Services Market growth is driven by rising infertility rates, increasing acceptance of assisted reproductive technologies, and advancements in treatment methods.

The global Fertility Services market is poised for substantial growth, projected to reach approximately USD 11,740 million by 2025, with an anticipated Compound Annual Growth Rate (CAGR) of 6.8% from 2019 to 2033. This robust expansion is driven by a confluence of factors, including increasing infertility rates worldwide, a growing awareness of fertility treatments, and advancements in Assisted Reproductive Technology (ART). Societal shifts such as delayed childbearing due to career pursuits and increased access to advanced medical interventions are significantly contributing to this upward trajectory. The market is segmented into Infertility Drugs and Assisted Reproductive Technology (ART), catering to both male and female applications. North America and Europe currently dominate the market, owing to well-established healthcare infrastructures and higher disposable incomes, enabling greater investment in fertility solutions. Emerging economies, particularly in the Asia Pacific region, are expected to witness accelerated growth due to a burgeoning middle class, improving healthcare accessibility, and a rising demand for family planning solutions. Key players like Merck, Cook Medical, Irvine Scientific, and CooperSurgical are at the forefront, investing heavily in research and development to introduce innovative products and services. While the market exhibits strong growth potential, certain restraints such as high treatment costs, ethical concerns, and varying regulatory landscapes across different regions may pose challenges. Nonetheless, the persistent need for effective fertility solutions and ongoing technological innovations are expected to propel the market forward, making it a dynamic and expanding sector within the global healthcare industry. This report provides an in-depth analysis of the global Fertility Services market, encompassing key players, product segments, regional dynamics, and critical trends. The market is projected to witness substantial growth driven by increasing infertility rates, technological advancements, and evolving societal norms. We estimate the current global market size for Fertility Services to be approximately USD 32,500 million, with a projected compound annual growth rate (CAGR) of around 7.2%. This growth is fueled by a confluence of factors, including delayed childbearing, rising environmental factors impacting fertility, and a greater awareness and acceptance of fertility treatments.

The India Fertility Services is projected to be valued at {Market_Size_2024} in 2024, driven by factors such as increasing consumer awareness and the rising prevalence of industry-specific trends. The market is expected to grow at a CAGR of {CAGR}, reaching approximately {Market_Size_2034} by 2034.

Thailand Fertility Services Market growth is driven by rising infertility rates, increasing acceptance of assisted reproductive technologies, and advancements in treatment methods.

The South America Fertility Services market will hit USD 4.38 Billion by 2030, driven by growing IVF adoption and large clinic networks.